Product information and disease descriptionProduct descriptionProduct informationDosing and administration
Dosage
1 evidence topic · 2 sources
Tinlarebant (LBS-008)
Stargardt disease type 1
- Manufacturer
- Belite Bio
- Regulatory submission
- NDA submitted June 2026
- Last updated